PDT Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
PDT Partners's HALO Position: Q4 2025 in Review
PDT Partners sold out of Halozyme (HALO) in Q4 2025, closing a stake of 67,685 shares — an estimated $4.96M sold.
PDT Partners first reported a position in HALO in Q1 2014 and held it in 23 quarters. The position peaked at $8.33M in Q4 2017. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.
- PDT Partners reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
- PDT Partners sold 67,685 Halozyme shares in Q4 2025, an estimated $4.96M.
- PDT Partners first reported a position in Halozyme in Q1 2014 and held it in 23 quarters.
- PDT Partners's Halozyme position peaked at $8.33M in Q4 2017.
- 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.
Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.